Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Commercial Officer

Chief Medical Officer

Chief Financial Officer

President and CEO

General Counsel

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated low density lipoprotein cholesterol. Its lead product candidates are NEXLETOL (bempedoic acid) and NEXLIZET (bempedoic acid and ezetimibe) tablets for the treatment of patients with atherosclerotic cardiovascular disease or heterozygous familial hypercholesterolemia. The company has a license and collaboration agreement with Daiichi Sankyo Europe GmbH; and Serometrix to in-license its oral, small molecule PCSK9 inhibitor program. Esperion Therapeutics, Inc. was incorporated in 2008 and is headquartered in Ann Arbor, Michigan.

Esperion Therapeutics, Inc., a pharmaceutical company, develops and commercializes medicines for the treatment of patients with elevated l...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief Commercial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-03-14	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-03-14	Premium	acquired	Premium	Premium	Premium	General Counsel
2023-09-20	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-08-18	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-07-19	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-06-21	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-06-15	Premium	acquired	Premium	Premium	Premium	-
2023-05-17	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-05-11	Premium	bought	Premium	Premium	Premium	-
2023-05-10	Premium	bought	Premium	Premium	Premium	-
2023-05-10	Premium	bought	Premium	Premium	Premium	-
2023-05-09	Premium	bought	Premium	Premium	Premium	President and CEO
2023-04-19	Premium	sold	Premium	Premium	Premium	Chief Commercial Officer
2023-04-19	Premium	sold	Premium	Premium	Premium	Chief Medical Officer
2023-04-19	Premium	sold	Premium	Premium	Premium	General Counsel

ESPR - Esperion Therapeutics Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for ESPR